Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/jspui/handle/10553/139952
| Title: | A randomized phase III study of ivonescimab versus pembrolizumab as first-line treatment of metastatic non-small cell lung cancer as first-line treatment of metastatic non-small cell lung cancer with high tumor PD-L1 expression: HARMONi-7 | Authors: | Passaro, A. Girard, N. Rodríguez Abreu, Delvys Gumus, M. Wu, Y-l. Syrigos, K. Ramlau, R. Santos, E. Berz, D. Gandhi, C. Vokes, N. Wang, B. Rotow, J. Paik, P. Weiss, J. Agulnik, J. Bai, X. Mcgovern, P. Blanco, A. Calles |
UNESCO Clasification: | 32 Ciencias médicas 3213 Cirugía |
Issue Date: | 2025 | Journal: | Journal of Thoracic Oncology | URI: | https://accedacris.ulpgc.es/handle/10553/139952 | ISSN: | 1556-0864 | Source: | Journal Of Thoracic Oncology[ISSN 1556-0864],v. 20 (3) sup. 1, Abstract 133TiP, (Marzo 2025) |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.